查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1812388

生物製劑市場

Biologics Market
出版日期: | 出版商: Transparency Market Research | 英文 213 Pages | 商品交期: 2-10個工作天內

價格

生物製劑市場 - 報告範圍

TMR 的全球生物製劑市場報告研究了過去和當前的成長趨勢和機遇，以獲得 2025 年至 2035 年預測期內市場指標的寶貴見解。該報告提供了 2025 年至 2035 年期間全球生物製劑市場的收入，以 2025 年為基準年，2035 年為預測年。該報告也提供了 2025 年至 2035 年全球生物製劑市場的年複合成長率(CAGR %)。

本報告經過廣泛的研究後編寫。主要研究工作量較大，分析師訪問了關鍵意見領袖、產業領袖和輿論領袖。次要研究則參考了主要廠商的產品資料、年度報告、新聞稿和相關文件，以了解二輪車導航顯示器市場。

市場概況
2024年的市場價值 4488億美元
2035年的市場價值 11402億美元
複合年成長率 8.8%

本報告深入探討了全球二輪車導航顯示器市場的競爭格局。報告確定了全球生物製劑市場的主要參與者，並根據其各項屬性進行了分析。本報告對全球生物製劑市場參與者的屬性進行了分析，涵蓋公司概況、財務狀況、近期發展和 SWOT 分析。

目錄

第1章：前言

第2章：假設與研究方法

第3章：執行摘要：全球市場

第4章：市場概況

  • 介紹
  • 概述
  • 市場動態
  • 2020年至2035年全球生物製劑市場分析與預測

第5章：關鍵見解

  • 重要產業事件
  • 波特五力分析
  • PESTEL分析
  • 疾病盛行率和發生率
  • 管道分析
  • 主要國家/地區的監管情況
  • 主要國家/地區報銷情況
  • 定價趨勢
  • 治療方案和選項
  • 最終用戶偏好

第6章：全球市場分析與預測：依產品類型

  • 介紹與定義
  • 主要發現/進展
  • 市場價值預測：依產品類型，2020 年至 2035 年
    • 單株抗體
    • 重組蛋白
    • 疫苗
    • 細胞和基因療法產品
    • 其他
  • 市場吸引力分析：按產品類型

第7章：全球市場分析與預測：依指標

  • 介紹與定義
  • 主要發現/進展
  • 市場價值預測：按適應症，2020 年至 2035 年
    • 腫瘤學
    • 自體免疫和免疫疾病
    • 血液系統疾病
    • 傳染病
    • 其他
  • 市場吸引力分析：按適應症

第8章：全球市場分析與預測：依製造業

  • 介紹與定義
  • 主要發現/進展
  • 市場價值預測：依製造業，2020 年至 2035 年
    • 外包
    • 內部
  • 市場吸引力分析：按製造業

第9章：全球市場分析與預測：按配銷通路

  • 介紹與定義
  • 主要發現/進展
  • 市場價值預測：按配銷通路，2020年至2035年
    • 零售藥局
    • 醫院藥房
    • 網路藥局
  • 市場吸引力分析：按配銷通路

第10章：全球市場分析與預測：按地區

  • 主要發現
  • 市場價值預測：按地區，2020年至2035年
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 各地區市場吸引力

第 11 章：北美市場分析與預測

第12章：歐洲市場分析與預測

第13章：亞太市場分析與預測

第 14 章：拉丁美洲市場分析與預測

第 15 章：中東和非洲市場分析與預測

第 16 章：競爭格局

  • 市場參與者 - 競爭矩陣（依公司層級和規模）
  • 市佔率分析：按公司（2024年）
  • 公司簡介
    • AbbVie, Inc.
    • Amgen
    • AstraZeneca plc
    • Bristol-Myers Squibb Company
    • Eli Lilly & Company
    • Gilead Sciences, Inc.
    • GSK plc
    • Johnson & Johnson Services, Inc.
    • Merck & Co., Inc.
    • Novartis AG
    • Pfizer, Inc.
    • F. Hoffmann-La Roche AG
    • Regeneron Pharmaceuticals Inc.
Product Code: TMRGL15509

Biologics Market - Scope of Report

TMR's report on the global Biologics Market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the Market during the forecast period from 2025 to 2035. The report provides revenue of the global Biologics Market for the period 2025 to 2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global Biologics Market from 2025 to 2035.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the Biologics Market .

Market Snapshot
Market Value in 2024US$ 448.8 Bn
Market Value in 2035US$ 1140.2 Bn
CAGR8.8%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global Biologics Market .

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global Biologics Market. These serve as valuable tools for existing Market players as well as for entities interested in participating in the global Biologics Market .

The report delves into the competitive landscape of the global Biologics Market. Key players operating in the global Biologics Market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global Biologics Market profiled in this report.

Key Questions Answered in Global Biologics Market Report:

  • What are the opportunities in the global Biologics Market ?
  • What are the major drivers, restraints, opportunities, and threats in the Market ?
  • Which regional Market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2035?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the Market positions of different companies operating in the global Market ?

Biologics Market - Research Objectives and Research Approach

The comprehensive report on the global Biologics Market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the Market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the Market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global Biologics Market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the Market share for each of these at the end of 2035 has been provided. Such valuable insights enable Market stakeholders in making informed business decisions for investment in the global Biologics Market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Biologics Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Biologics Market Analysis and Forecast, 2020 to 2035
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

  • 5.1. Key Industry Events
  • 5.2. Porter's Five Forces Analysis
  • 5.3. PESTEL Analysis
  • 5.4. Disease Prevalence & Incidence Rate
  • 5.5. Pipeline Analysis
  • 5.6. Regulatory Scenario by Key Countries/Regions
  • 5.7. Reimbursement Scenario by Key Countries/Regions
  • 5.8. Pricing Trends
  • 5.9. Treatment Algorithm & Options
  • 5.10. End-user Preference

6. Global Biologics Market Analysis and Forecast, by Product Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Product Type, 2020 to 2035
    • 6.3.1. Monoclonal Antibodies
    • 6.3.2. Recombinant Proteins
    • 6.3.3. Vaccines
    • 6.3.4. Cell & Gene Therapy Products
    • 6.3.5. Others
  • 6.4. Market Attractiveness Analysis, by Product Type

7. Global Biologics Market Analysis and Forecast, by Indication

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Indication, 2020 to 2035
    • 7.3.1. Oncology
    • 7.3.2. Autoimmune & Immunological Disorders
    • 7.3.3. Hematological Disorders
    • 7.3.4. Infectious Diseases
    • 7.3.5. Others
  • 7.4. Market Attractiveness Analysis, by Indication

8. Global Biologics Market Analysis and Forecast, by Manufacturing

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by Manufacturing, 2020 to 2035
    • 8.3.1. Outsourced
    • 8.3.2. In-house
  • 8.4. Market Attractiveness Analysis, by Manufacturing

9. Global Biologics Market Analysis and Forecast, by Distribution Channel

  • 9.1. Introduction & Definition
  • 9.2. Key Findings/Developments
  • 9.3. Market Value Forecast, by Distribution Channel, 2020 to 2035
    • 9.3.1. Retail Pharmacies
    • 9.3.2. Hospital Pharmacies
    • 9.3.3. Online Pharmacies
  • 9.4. Market Attractiveness Analysis, by Distribution Channel

10. Global Biologics Market Analysis and Forecast, by Region

  • 10.1. Key Findings
  • 10.2. Market Value Forecast, by Region, 2020 to 2035
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Market Attractiveness By Region

11. North America Biologics Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Product Type, 2020 to 2035
    • 11.2.1. Monoclonal Antibodies
    • 11.2.2. Recombinant Proteins
    • 11.2.3. Vaccines
    • 11.2.4. Cell & Gene Therapy Products
    • 11.2.5. Others
  • 11.3. Market Value Forecast, by Indication, 2020 to 2035
    • 11.3.1. Oncology
    • 11.3.2. Autoimmune & Immunological Disorders
    • 11.3.3. Hematological Disorders
    • 11.3.4. Infectious Diseases
    • 11.3.5. Others
  • 11.4. Market Value Forecast, by Manufacturing, 2020 to 2035
    • 11.4.1. Outsourced
    • 11.4.2. In-house
  • 11.5. Market Value Forecast, by Distribution Channel, 2020 to 2035
    • 11.5.1. Retail Pharmacies
    • 11.5.2. Hospital Pharmacies
    • 11.5.3. Online Pharmacies
  • 11.6. Market Value Forecast, by Country, 2020 to 2035
    • 11.6.1. U.S.
    • 11.6.2. Canada
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Product Type
    • 11.7.2. By Indication
    • 11.7.3. By Manufacturing
    • 11.7.4. By Distribution Channel
    • 11.7.5. By Country

12. Europe Biologics Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Product Type, 2020 to 2035
    • 12.2.1. Monoclonal Antibodies
    • 12.2.2. Recombinant Proteins
    • 12.2.3. Vaccines
    • 12.2.4. Cell & Gene Therapy Products
    • 12.2.5. Others
  • 12.3. Market Value Forecast, by Indication, 2020 to 2035
    • 12.3.1. Oncology
    • 12.3.2. Autoimmune & Immunological Disorders
    • 12.3.3. Hematological Disorders
    • 12.3.4. Infectious Diseases
    • 12.3.5. Others
  • 12.4. Market Value Forecast, by Manufacturing, 2020 to 2035
    • 12.4.1. Outsourced
    • 12.4.2. In-house
  • 12.5. Market Value Forecast, by Distribution Channel, 2020 to 2035
    • 12.5.1. Retail Pharmacies
    • 12.5.2. Hospital Pharmacies
    • 12.5.3. Online Pharmacies
  • 12.6. Market Value Forecast, by Country/Sub-region, 2020 to 2035
    • 12.6.1. Germany
    • 12.6.2. U.K.
    • 12.6.3. France
    • 12.6.4. Italy
    • 12.6.5. Spain
    • 12.6.6. Switzerland
    • 12.6.7. The Netherlands
    • 12.6.8. Rest of Europe
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Product Type
    • 12.7.2. By Indication
    • 12.7.3. By Manufacturing
    • 12.7.4. By Distribution Channel
    • 12.7.5. By Country/Sub-region

13. Asia Pacific Biologics Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Product Type, 2020 to 2035
    • 13.2.1. Monoclonal Antibodies
    • 13.2.2. Recombinant Proteins
    • 13.2.3. Vaccines
    • 13.2.4. Cell & Gene Therapy Products
    • 13.2.5. Others
  • 13.3. Market Value Forecast, by Indication, 2020 to 2035
    • 13.3.1. Oncology
    • 13.3.2. Autoimmune & Immunological Disorders
    • 13.3.3. Hematological Disorders
    • 13.3.4. Infectious Diseases
    • 13.3.5. Others
  • 13.4. Market Value Forecast, by Manufacturing, 2020 to 2035
    • 13.4.1. Outsourced
    • 13.4.2. In-house
  • 13.5. Market Value Forecast, by Distribution Channel, 2020 to 2035
    • 13.5.1. Retail Pharmacies
    • 13.5.2. Hospital Pharmacies
    • 13.5.3. Online Pharmacies
  • 13.6. Market Value Forecast, by Country/Sub-region, 2020 to 2035
    • 13.6.1. China
    • 13.6.2. India
    • 13.6.3. Japan
    • 13.6.4. South Korea
    • 13.6.5. Australia & New Zealand
    • 13.6.6. Rest of Asia Pacific
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Product Type
    • 13.7.2. By Indication
    • 13.7.3. By Manufacturing
    • 13.7.4. By Distribution Channel
    • 13.7.5. By Country/Sub-region

14. Latin America Biologics Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Product Type, 2020 to 2035
    • 14.2.1. Monoclonal Antibodies
    • 14.2.2. Recombinant Proteins
    • 14.2.3. Vaccines
    • 14.2.4. Cell & Gene Therapy Products
    • 14.2.5. Others
  • 14.3. Market Value Forecast, by Indication, 2020 to 2035
    • 14.3.1. Oncology
    • 14.3.2. Autoimmune & Immunological Disorders
    • 14.3.3. Hematological Disorders
    • 14.3.4. Infectious Diseases
    • 14.3.5. Others
  • 14.4. Market Value Forecast, by Manufacturing, 2020 to 2035
    • 14.4.1. Outsourced
    • 14.4.2. In-house
  • 14.5. Market Value Forecast, by Distribution Channel, 2020 to 2035
    • 14.5.1. Retail Pharmacies
    • 14.5.2. Hospital Pharmacies
    • 14.5.3. Online Pharmacies
  • 14.6. Market Value Forecast, by Country/Sub-region, 2020 to 2035
    • 14.6.1. Brazil
    • 14.6.2. Mexico
    • 14.6.3. Argentina
    • 14.6.4. Rest of Latin America
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Product Type
    • 14.7.2. By Indication
    • 14.7.3. By Manufacturing
    • 14.7.4. By Distribution Channel
    • 14.7.5. By Country/Sub-region

15. Middle East & Africa Biologics Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Product Type, 2020 to 2035
    • 15.2.1. Monoclonal Antibodies
    • 15.2.2. Recombinant Proteins
    • 15.2.3. Vaccines
    • 15.2.4. Cell & Gene Therapy Products
    • 15.2.5. Others
  • 15.3. Market Value Forecast, by Indication, 2020 to 2035
    • 15.3.1. Oncology
    • 15.3.2. Autoimmune & Immunological Disorders
    • 15.3.3. Hematological Disorders
    • 15.3.4. Infectious Diseases
    • 15.3.5. Others
  • 15.4. Market Value Forecast, by Manufacturing, 2020 to 2035
    • 15.4.1. Outsourced
    • 15.4.2. In-house
  • 15.5. Market Value Forecast, by Distribution Channel, 2020 to 2035
    • 15.5.1. Retail Pharmacies
    • 15.5.2. Hospital Pharmacies
    • 15.5.3. Online Pharmacies
  • 15.6. Market Value Forecast, by Country/Sub-region, 2020 to 2035
    • 15.6.1. GCC Countries
    • 15.6.2. South Africa
    • 15.6.3. Rest of Middle East & Africa
  • 15.7. Market Attractiveness Analysis
    • 15.7.1. By Product Type
    • 15.7.2. By Indication
    • 15.7.3. By Manufacturing
    • 15.7.4. By Distribution Channel
    • 15.7.5. By Country/Sub-region

16. Competition Landscape

  • 16.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 16.2. Market Share Analysis, by Company (2024)
  • 16.3. Company Profiles
    • 16.3.1. AbbVie, Inc.
      • 16.3.1.1. Company Overview
      • 16.3.1.2. Financial Overview
      • 16.3.1.3. Product Portfolio
      • 16.3.1.4. Business Strategies
      • 16.3.1.5. Recent Developments
    • 16.3.2. Amgen
      • 16.3.2.1. Company Overview
      • 16.3.2.2. Financial Overview
      • 16.3.2.3. Product Portfolio
      • 16.3.2.4. Business Strategies
      • 16.3.2.5. Recent Developments
    • 16.3.3. AstraZeneca plc
      • 16.3.3.1. Company Overview
      • 16.3.3.2. Financial Overview
      • 16.3.3.3. Product Portfolio
      • 16.3.3.4. Business Strategies
      • 16.3.3.5. Recent Developments
    • 16.3.4. Bristol-Myers Squibb Company
      • 16.3.4.1. Company Overview
      • 16.3.4.2. Financial Overview
      • 16.3.4.3. Product Portfolio
      • 16.3.4.4. Business Strategies
      • 16.3.4.5. Recent Developments
    • 16.3.5. Eli Lilly & Company
      • 16.3.5.1. Company Overview
      • 16.3.5.2. Financial Overview
      • 16.3.5.3. Product Portfolio
      • 16.3.5.4. Business Strategies
      • 16.3.5.5. Recent Developments
    • 16.3.6. Gilead Sciences, Inc.
      • 16.3.6.1. Company Overview
      • 16.3.6.2. Financial Overview
      • 16.3.6.3. Product Portfolio
      • 16.3.6.4. Business Strategies
      • 16.3.6.5. Recent Developments
    • 16.3.7. GSK plc
      • 16.3.7.1. Company Overview
      • 16.3.7.2. Financial Overview
      • 16.3.7.3. Product Portfolio
      • 16.3.7.4. Business Strategies
      • 16.3.7.5. Recent Developments
    • 16.3.8. Johnson & Johnson Services, Inc.
      • 16.3.8.1. Company Overview
      • 16.3.8.2. Financial Overview
      • 16.3.8.3. Product Portfolio
      • 16.3.8.4. Business Strategies
      • 16.3.8.5. Recent Developments
    • 16.3.9. Merck & Co., Inc.
      • 16.3.9.1. Company Overview
      • 16.3.9.2. Financial Overview
      • 16.3.9.3. Product Portfolio
      • 16.3.9.4. Business Strategies
      • 16.3.9.5. Recent Developments
    • 16.3.10. Novartis AG
      • 16.3.10.1. Company Overview
      • 16.3.10.2. Financial Overview
      • 16.3.10.3. Product Portfolio
      • 16.3.10.4. Business Strategies
      • 16.3.10.5. Recent Developments
    • 16.3.11. Pfizer, Inc.
      • 16.3.11.1. Company Overview
      • 16.3.11.2. Financial Overview
      • 16.3.11.3. Product Portfolio
      • 16.3.11.4. Business Strategies
      • 16.3.11.5. Recent Developments
    • 16.3.12. F. Hoffmann-La Roche AG
      • 16.3.12.1. Company Overview
      • 16.3.12.2. Financial Overview
      • 16.3.12.3. Product Portfolio
      • 16.3.12.4. Business Strategies
      • 16.3.12.5. Recent Developments
    • 16.3.13. Regeneron Pharmaceuticals Inc.
      • 16.3.13.1. Company Overview
      • 16.3.13.2. Financial Overview
      • 16.3.13.3. Product Portfolio
      • 16.3.13.4. Business Strategies
      • 16.3.13.5. Recent Developments

List of Tables

  • Table 01: Global Biologics Market Value (US$ Mn) Forecast, by Product Type, 2020 to 2035
  • Table 02: Global Biologics Market Value (US$ Mn) Forecast, By Indication, 2020 to 2035
  • Table 03: Global Biologics Market Value (US$ Mn) Forecast, By Manufacturing, 2020 to 2035
  • Table 04: Global Biologics Market Value (US$ Mn) Forecast, by Distribution Channel, 2020 to 2035
  • Table 05: Global Biologics Market Value (US$ Mn) Forecast, By Region, 2020 to 2035
  • Table 06: North America Biologics Market Value (US$ Mn) Forecast, by Country, 2020 to 2035
  • Table 07: North America Biologics Market Value (US$ Mn) Forecast, by Product Type, 2020 to 2035
  • Table 08: North America Biologics Market Value (US$ Mn) Forecast, by Indication, 2020 to 2035
  • Table 09: North America Biologics Market Value (US$ Mn) Forecast, By Manufacturing, 2020 to 2035
  • Table 10: North America Biologics Market Value (US$ Mn) Forecast, by Distribution Channel, 2020 to 2035
  • Table 11: Europe Biologics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020 to 2035
  • Table 12: Europe Biologics Market Value (US$ Mn) Forecast, by Product Type, 2020 to 2035
  • Table 13: Europe Biologics Market Value (US$ Mn) Forecast, by Indication, 2020 to 2035
  • Table 14: Europe Biologics Market Value (US$ Mn) Forecast, By Manufacturing, 2020 to 2035
  • Table 15: Europe Biologics Market Value (US$ Mn) Forecast, by Distribution Channel, 2020 to 2035
  • Table 16: Asia Pacific Biologics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020 to 2035
  • Table 17: Asia Pacific Biologics Market Value (US$ Mn) Forecast, by Product Type, 2020 to 2035
  • Table 18: Asia Pacific Biologics Market Value (US$ Mn) Forecast, by Indication, 2020 to 2035
  • Table 19: Asia Pacific Biologics Market Value (US$ Mn) Forecast, By Manufacturing, 2020 to 2035
  • Table 20: Asia Pacific Biologics Market Value (US$ Mn) Forecast, by Distribution Channel, 2020 to 2035
  • Table 21: Latin America Biologics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020 to 2035
  • Table 22: Latin America Biologics Market Value (US$ Mn) Forecast, by Product Type, 2020 to 2035
  • Table 23: Latin America Biologics Market Value (US$ Mn) Forecast, by Indication, 2020 to 2035
  • Table 24: Latin America Biologics Market Value (US$ Mn) Forecast, By Manufacturing, 2020 to 2035
  • Table 25: Latin America Biologics Market Value (US$ Mn) Forecast, by Distribution Channel, 2020 to 2035
  • Table 26: Middle East & Africa Biologics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020 to 2035
  • Table 27: Middle East and Africa Biologics Market Value (US$ Mn) Forecast, by Product Type, 2020 to 2035
  • Table 28: Middle East and Africa Biologics Market Value (US$ Mn) Forecast, by Indication, 2020 to 2035
  • Table 29: Middle East and Africa Biologics Market Value (US$ Mn) Forecast, By Manufacturing, 2020 to 2035
  • Table 30: Middle East and Africa Biologics Market Value (US$ Mn) Forecast, by Distribution Channel, 2020 to 2035

List of Figures

  • Figure 01: Global Biologics Market Value Share Analysis, by Product Type, 2024 and 2035
  • Figure 02: Global Biologics Market Attractiveness Analysis, by Product Type, 2025 to 2035
  • Figure 03: Global Biologics Market Revenue (US$ Mn), by Monoclonal Antibodies, 2020 to 2035
  • Figure 04: Global Biologics Market Revenue (US$ Mn), by Recombinant Proteins, 2020 to 2035
  • Figure 05: Global Biologics Market Revenue (US$ Mn), by Vaccines, 2020 to 2035
  • Figure 06: Global Biologics Market Revenue (US$ Mn), by Cell & Gene Therapy Products, 2020 to 2035
  • Figure 07: Global Biologics Market Revenue (US$ Mn), by Others, 2020 to 2035
  • Figure 08: Global Biologics Market Value Share Analysis, by Indication, 2024 and 2035
  • Figure 09: Global Biologics Market Attractiveness Analysis, by Indication, 2025 to 2035
  • Figure 10: Global Biologics Market Revenue (US$ Mn), by Oncology, 2020 to 2035
  • Figure 11: Global Biologics Market Revenue (US$ Mn), by Autoimmune & Immunological Disorders, 2020 to 2035
  • Figure 12: Global Biologics Market Revenue (US$ Mn), by Hematological Disorders, 2020 to 2035
  • Figure 13: Global Biologics Market Revenue (US$ Mn), by Infectious Diseases, 2020 to 2035
  • Figure 14: Global Biologics Market Revenue (US$ Mn), by Others, 2020 to 2035
  • Figure 15: Global Biologics Market Value Share Analysis, by Manufacturing, 2024 and 2035
  • Figure 16: Global Biologics Market Attractiveness Analysis, by Manufacturing, 2025 to 2035
  • Figure 17: Global Biologics Market Revenue (US$ Mn), by Outsourced, 2020 to 2035
  • Figure 18: Global Biologics Market Revenue (US$ Mn), by In-house, 2020 to 2035
  • Figure 19: Global Biologics Market Value Share Analysis, by Distribution Channel, 2024 and 2035
  • Figure 20: Global Biologics Market Attractiveness Analysis, by Distribution Channel, 2025 to 2035
  • Figure 21: Global Biologics Market Revenue (US$ Mn), by Retail Pharmacies , 2020 to 2035
  • Figure 22: Global Biologics Market Revenue (US$ Mn), by Hospital Pharmacies, 2020 to 2035
  • Figure 23: Global Biologics Market Revenue (US$ Mn), by Online Pharmacies, 2020 to 2035
  • Figure 24: Global Biologics Market Value Share Analysis, By Region, 2024 and 2035
  • Figure 25: Global Biologics Market Attractiveness Analysis, By Region, 2025 to 2035
  • Figure 26: North America Biologics Market Value (US$ Mn) Forecast, 2020 to 2035
  • Figure 27: North America Biologics Market Value Share Analysis, by Country, 2024 and 2035
  • Figure 28: North America Biologics Market Attractiveness Analysis, by Country, 2025 to 2035
  • Figure 29: North America Biologics Market Value Share Analysis, by Product Type, 2024 and 2035
  • Figure 30: North America Biologics Market Attractiveness Analysis, by Product Type, 2025 to 2035
  • Figure 31: North America Biologics Market Value Share Analysis, by Indication, 2025 to 2035
  • Figure 32: North America Biologics Market Attractiveness Analysis, by Indication, 2025 to 2035
  • Figure 33: North America Biologics Market Value Share Analysis, by Manufacturing, 2024 and 2035
  • Figure 34: North America Biologics Market Attractiveness Analysis, by Manufacturing, 2025 to 2035
  • Figure 35: North America Biologics Market Value Share Analysis, by Distribution Channel, 2024 and 2035
  • Figure 36: North America Biologics Market Attractiveness Analysis, by Distribution Channel, 2025 to 2035
  • Figure 37: Europe Biologics Market Value (US$ Mn) Forecast, 2020 to 2035
  • Figure 38: Europe Biologics Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
  • Figure 39: Europe Biologics Market Attractiveness Analysis, by Country/Sub-region, 2025 to 2035
  • Figure 40: Europe Biologics Market Value Share Analysis, by Product Type, 2024 and 2035
  • Figure 41: Europe Biologics Market Attractiveness Analysis, by Product Type, 2025 to 2035
  • Figure 42: Europe Biologics Market Value Share Analysis, by Indication, 2025 to 2035
  • Figure 43: Europe Biologics Market Attractiveness Analysis, by Indication, 2024 and 2035
  • Figure 44: Europe Biologics Market Value Share Analysis, By Manufacturing, 2024 and 2035
  • Figure 45: Europe Biologics Market Attractiveness Analysis, By Manufacturing, 2025 to 2035
  • Figure 46: Europe Biologics Market Value Share Analysis, by Distribution Channel, 2024 and 2035
  • Figure 47: Europe Biologics Market Attractiveness Analysis, by Distribution Channel, 2025 to 2035
  • Figure 48: Asia Pacific Biologics Market Value (US$ Mn) Forecast, 2020 to 2035
  • Figure 49: Asia Pacific Biologics Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
  • Figure 50: Asia Pacific Biologics Market Attractiveness Analysis, by Country/Sub-region, 2025 to 2035
  • Figure 51: Asia Pacific Biologics Market Value Share Analysis, by Product Type, 2024 and 2035
  • Figure 52: Asia Pacific Biologics Market Attractiveness Analysis, by Product Type, 2025 to 2035
  • Figure 53: Asia Pacific Biologics Market Value Share Analysis, by Indication, 2025 to 2035
  • Figure 54: Asia Pacific Biologics Market Attractiveness Analysis, by Indication, 2024 and 2035
  • Figure 55: Asia Pacific Biologics Market Value Share Analysis, By Manufacturing, 2024 and 2035
  • Figure 56: Asia Pacific Biologics Market Attractiveness Analysis, By Manufacturing, 2025 to 2035
  • Figure 57: Asia Pacific Biologics Market Value Share Analysis, by Distribution Channel, 2024 and 2035
  • Figure 58: Asia Pacific Biologics Market Attractiveness Analysis, by Distribution Channel, 2025 to 2035
  • Figure 59: Latin America Biologics Market Value (US$ Mn) Forecast, 2020 to 2035
  • Figure 60: Latin America Biologics Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
  • Figure 61: Latin America Biologics Market Attractiveness Analysis, by Country/Sub-region, 2025 to 2035
  • Figure 62: Latin America Biologics Market Value Share Analysis, by Product Type, 2024 and 2035
  • Figure 63: Latin America Biologics Market Attractiveness Analysis, by Product Type, 2025 to 2035
  • Figure 64: Latin America Biologics Market Value Share Analysis, by Indication, 2025 to 2035
  • Figure 65: Latin America Biologics Market Attractiveness Analysis, by Indication, 2024 and 2035
  • Figure 66: Latin America Biologics Market Value Share Analysis, By Manufacturing, 2024 and 2035
  • Figure 67: Latin America Biologics Market Attractiveness Analysis, By Manufacturing, 2025 to 2035
  • Figure 68: Latin America Biologics Market Value Share Analysis, by Distribution Channel, 2024 and 2035
  • Figure 69: Latin America Biologics Market Attractiveness Analysis, by Distribution Channel, 2025 to 2035
  • Figure 70: Middle East & Africa Biologics Market Value (US$ Mn) Forecast, 2020 to 2035
  • Figure 71: Middle East & Africa Biologics Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
  • Figure 72: Middle East & Africa Biologics Market Attractiveness Analysis, by Country/Sub-region, 2025 to 2035
  • Figure 73: Middle East and Africa Biologics Market Value Share Analysis, by Product Type, 2024 and 2035
  • Figure 74: Middle East and Africa Biologics Market Attractiveness Analysis, by Product Type, 2025 to 2035
  • Figure 75: Middle East and Africa Biologics Market Value Share Analysis, by Indication, 2025 to 2035
  • Figure 76: Middle East and Africa Biologics Market Attractiveness Analysis, by Indication, 2024 and 2035
  • Figure 77: Middle East and Africa Biologics Market Value Share Analysis, by Manufacturing, 2024 and 2035
  • Figure 78: Middle East and Africa Biologics Market Attractiveness Analysis, By Manufacturing, 2025 to 2035
  • Figure 79: Middle East and Africa Biologics Market Value Share Analysis, by Distribution Channel, 2024 and 2035
  • Figure 80: Middle East and Africa Biologics Market Attractiveness Analysis, by Distribution Channel, 2025 to 2035